Has Lyle Myers, MD received payments from drug or device companies?

Yes. Drug and device makers reported $433,619 in general payments to Lyle Myers, MD across 960 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lyle Myers, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lyle Myers, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lyle Myers, MD

Endocrinology, Diabetes & Metabolism · Lexington, KYNPI 1255493342

Payments from drug & device makers

$433,619in general payments, 2019–2025

Across 960 payments — averaging $451.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk AS$301K
Sanofi US Services Inc.$73K
Sanofi-aventis U.S. LLC$19K
Boehringer Ingelheim$17K
AstraZeneca$7K
Lilly USA, LLC$6K
plus $11K from 40 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk AS	308	$301,154
Sanofi US Services Inc.	12	$72,577
Sanofi-aventis U.S. LLC	62	$19,043
Boehringer Ingelheim	83	$16,833
AstraZeneca(2 entities)	54	$7,497
Lilly USA, LLC	30	$5,837
Merck	28	$3,998
Novo Nordisk	84	$1,048
Dexcom, Inc.	23	$779
Abbott	37	$724
Mannkind Corporation	48	$702
Medtronic(2 entities)	18	$578
Amarin Pharma, Inc.	24	$391
AbbVie	22	$353
Amgen(2 entities)	16	$264
Xeris Pharmaceuticals, Inc.	11	$226
Insulet Corporation	8	$172
Bayer	10	$147
Antares Pharma, Inc.	7	$137
Tandem Diabetes Care, Inc.	7	$116
Zealand Pharma US, Inc.	8	$110
Johnson & Johnson	9	$109
BD	4	$94
Corcept Therapeutics	5	$74
IBSA Pharma Inc.	5	$70
Radius Health, Inc.	4	$63
Esperion Therapeutics, Inc.	4	$60
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	4	$59
Amryt Pharma Holdings Ltd	3	$55
Halozyme Inc	2	$43
Takeda Pharmaceuticals U.S.A., Inc.	3	$38
Shire North American Group Inc	2	$32
Shionogi Inc	2	$32
Melinta Therapeutics, LLC	1	$22
Sequel Med Tech, LLC	1	$20
Lifescan, Inc.	1	$19
Alfasigma USA, Inc.	1	$18
Aimmune Therapeutics, Inc.	1	$17
Neurocrine Biosciences, Inc.	1	$17
Pfizer	1	$17
Recordati_rare_diseases_inc.	1	$16
Ascendis Pharma Endocrinology Inc	1	$16
Azurity Pharmaceuticals, Inc.	1	$15
Ultragenyx Pharmaceutical Inc.	1	$15
Kowa Pharmaceuticals America, Inc.	1	$12
BETA Bionics, Inc.	1	$3

How this compares

$433,619 in reported general payments places this provider in the 90th percentile of 90 endocrinology, diabetes & metabolism providers in Kentucky.

See all endocrinology, diabetes & metabolism providers in Kentucky →

Medicare billing

Part B allowed, 2024

$93,002

Medicare patients

532

Services billed

1,808

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Lexington

Dennis KarounosLexington$212K
Wendell MiersLexington$182K
Kenneth AinLexington$166K
Leera PatelLexington$34K
Simon FisherLexington$26K
Anna MarinoLexington$23K
Gordon GuthrieLexington$14K
Megan MinchLexington$4K
Walaa AyoubLexington$3K
Kristina HumphriesLexington$3K

See the full list for Kentucky →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →